93 related articles for article (PubMed ID: 208247)
1. Characterization of a DNA-binding phosphoprotein from vaccinia virus replication complex.
Nowakowski M; Bauer W; Kates J
Virology; 1978 May; 86(1):217-25. PubMed ID: 208247
[No Abstract] [Full Text] [Related]
2. Isolation of two DNA-binding proteins from the intracellular replication complex of vaccinia virus.
Nowakowski M; Kates J; Bauer W
Virology; 1978 Feb; 84(2):260-7. PubMed ID: 203092
[No Abstract] [Full Text] [Related]
3. Phosphoprotein component of vaccinia virions.
Rosemond H; Moss B
J Virol; 1973 Jun; 11(6):961-70. PubMed ID: 4712965
[TBL] [Abstract][Full Text] [Related]
4. DNA-binding proteins in the cytoplasm of vaccinia virus-infected mouse L-cells.
Soloski MJ; Esteban M; Holowczak JA
J Virol; 1978 Jan; 25(1):263-73. PubMed ID: 202739
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus intracellular DNA-protein complex: biochemical characteristics of associated protein.
Polisky B; Kates J
Virology; 1972 Jul; 49(1):168-79. PubMed ID: 4261046
[No Abstract] [Full Text] [Related]
6. Studies on the nature and location of the capsid polypeptides of vaccinia virions.
Sarov I; Joklik WK
Virology; 1972 Nov; 50(2):579-92. PubMed ID: 4117937
[No Abstract] [Full Text] [Related]
7. Isolation and characterization of low-molecular-weight DNA-binding proteins from retroviruses.
Long CW; Henderson LE; Oroszlan S
Virology; 1980 Jul; 104(2):491-6. PubMed ID: 6249039
[No Abstract] [Full Text] [Related]
8. Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.
Essani K; Dales S
Virology; 1979 Jun; 95(2):385-94. PubMed ID: 462799
[No Abstract] [Full Text] [Related]
9. Identification of the protein firmly bound to the ends of bacteriophage phi 29 DNA.
Harding NE; Ito J; David GS
Virology; 1978 Feb; 84(2):279-92. PubMed ID: 203093
[No Abstract] [Full Text] [Related]
10. Isolation and characterization of intermediates in vaccinia virus morphogenesis.
Sarov I; Joklik WK
Virology; 1973 Mar; 52(1):223-33. PubMed ID: 4807816
[No Abstract] [Full Text] [Related]
11. Endogenous protein kinase and phosphate acceptor proteins in vaccinia virus.
Downer DN; Rogers HW; Randall CC
Virology; 1973 Mar; 52(1):13-21. PubMed ID: 4803391
[No Abstract] [Full Text] [Related]
12. Location of vaccinia virus structural polypeptides on the surface of the virus particle.
Katz E; Margalith E
J Gen Virol; 1973 Mar; 18(3):381-4. PubMed ID: 4696556
[No Abstract] [Full Text] [Related]
13. A phosphorylated basic vaccinia virion polypeptide of molecular weight 11,000 is exposed on the surface of mature particles and interacts with actin-containing cytoskeletal elements.
Hiller G; Weber K
J Virol; 1982 Nov; 44(2):647-57. PubMed ID: 6890583
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein synthesis in cells infected with vaccinia virus. 3. Purification and biosynthesis of the virion glycoprotein.
Moss B; Rosenblum EN; Garon CF
Virology; 1973 Sep; 55(1):143-56. PubMed ID: 4728825
[No Abstract] [Full Text] [Related]
15. Purification and location of the major glycoprotein of vaccinia virus.
Boisvert J; Yamamoto T
Microbios; 1976; 16(63):55-72. PubMed ID: 1026850
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a superhelix binding protein from vaccinia virus.
Kao SY; Ressner E; Kates J; Bauer WR
Virology; 1981 Jun; 111(2):500-8. PubMed ID: 6894655
[No Abstract] [Full Text] [Related]
17. Polyacrylamide gel electrophoresis of fowlpox and vaccinia virus proteins.
Obijeski JF; Palmer EL; Gafford LG; Randall CC
Virology; 1973 Feb; 51(2):512-6. PubMed ID: 4348307
[No Abstract] [Full Text] [Related]
18. Isolation and characterization of vaccinia virus "nucleoids".
Holowczak JA; Thomas VI; Flores L
Virology; 1975 Oct; 67(2):506-19. PubMed ID: 1189287
[No Abstract] [Full Text] [Related]
19. Characterization of intermediates in the uncoating of vaccinia virus DNA.
Sarov I; Joklik WK
Virology; 1972 Nov; 50(2):593-602. PubMed ID: 4117938
[No Abstract] [Full Text] [Related]
20. Studies concerning the structure and organization of the vaccinia virus nucleoid. I. Isolation and characterization of subviral particles prepared by treating virions with guanidine-HCL, nonidet-P40, and 2-mercaptoethanol.
Soloski MJ; Cabrera CV; Esteban M; Holowczak JA
Virology; 1979 Dec; 99(2):209-17. PubMed ID: 516446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
